Prevalence of metastases outside the liver and abdominal lymph nodes on 68 Ga‐DOTATOC‐PET / CT in patients with small intestinal and pancreatic neuroendocrine tumours

Documenti analoghi

• Impact on symptoms and survival of bone metastases in patients with small‐intestinal neuroendocrine tumours
  di: Maria Wedin, et al.
  Pubblicazione: (2025)
• Phosphohistone H3 and Ki‐67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective cohort study
  di: Dimitrios Papantoniou, et al.
  Pubblicazione: (2026)
• Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours
  di: Stefano Partelli, et al.
  Pubblicazione: (2026)
• Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio ( dNLR ), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy : A retrospective, cohort study of 557 patients
  di: Dimitrios Papantoniou, et al.
  Pubblicazione: (2024)
• European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours
  di: Angela Lamarca, et al.
  Pubblicazione: (2024)